Revolution Medicines Inc. RVMD
$156.22
▲ +3.11% 24H
About
Revolution Medicines Inc. is a clinical-stage precision oncology company focused on developing targeted cancer therapies. The company concentrates on inhibiting difficult-to-drug molecular targets within key cell growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways that are freq…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees883
TickerRVMD
Statistics
Market Cap$31.27B
Revenue (TTM)$0
Net Income-$1.13B
Net Margin—
EPS$-5.95
P/E-25.86
P/S—
P/B19.92
EV/EBITDA-21.17
ROE-76.7%
Dividend Yield—
Price$156.22
Data: Twelve Data · Revenue = mcap / P/S